Allergy, Asthma, and Clinical Research Center

Oklahoma City, Oklahoma 73120

2 studies enrolling now · 25 studies all time

What they study most

Allergic Rhinitis, Allergic Rhinitis Due to Cat Allergy, Asthma, Atopic Dermatitis, Chronic Inducible Urticaria, Chronic Rhinosinusitis Without Nasal Polyps, Chronic Spontaneous Urticaria, Cow Milk Allergy, Eosinophilic Duodenitis (EoD), Eosinophilic Gastritis (EoG), Eosinophilic Gastroenteritis, Eosinophilic Gastrointestinal Disease (EGID)

Studies at this site

• A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atopic Dermatitis — Recruiting now
• Efficacy and Safety of 186 mcg of OPN-375 Nasal Spray Twice a Day (BID) in Adolescents With Chronic Rhinosinusitis Without Nasal Polyps — Recruiting now
• An Open-label, Multicenter Study to Assess the Pharmacokinetics (PK), Safety, and Tolerability of Subcutaneous IgPro20 in Immunoglobulin (IG) Treatment-naïve Participants With Primary Immunodeficiency (PID) — Completed
• A Study to Learn How Well Dupilumab Works in Adult and Adolescent Participants With Eosinophilic Gastritis With or Without Eosinophilic Duodenitis and the Side Effects it May Have — Running, not enrolling
• A Phase 1, Randomized, Double-blind, Placebo-controlled Study Evaluating AMG 691 in Healthy Participants and Participants With Mild-to-Moderate Asthma — Running, not enrolling
• Registry of Asthma Patients Initiating DUPIXENT® — Completed
• Efficacy of Dupilumab Added to Medium Dose Inhaled Corticosteroid/Long-acting Beta-agonist (ICS/LABA) in Comparison to ICS Dose Escalation to High Dose ICS/LABA in Adolescent and Adult Patients With Uncontrolled Asthma — Running, not enrolling
• A Study Evaluating the Safety, Tolerability, and Efficacy of EVO756 in Adults With Chronic Inducible Urticaria — Completed
• A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria — Running, not enrolling
• A Study to Assess the Efficacy and Safety of Daily OM-85 in Young Children With Recurrent Wheezing — Running, not enrolling
• A Study to Examine the Efficacy and Safety of Anti-Fel d 1 Antibodies Injections in Cat-allergic Adolescent and Adult Patients With Allergic Rhinitis Who Live With a Cat — Stopped early
• A Study to Evaluate IGSC 20% Biweekly Dosing in Treatment-Experienced Participants and Loading/Maintenance Dosing in Treatment-Naïve Participants With Primary Immunodeficiency — Completed
• Non-Interventional Post-Marketing Safety Study on the Long-Term Safety of HYQVIA (Global) — Completed
• Efficacy and Safety Study of TOLAMBA™ in Ragweed-Allergic Adults — Stopped early
• Hypoallergenicity Evaluation of a New Extensively Hydrolyzed Formula — Completed
• Formula for Children With Cow's Milk Allergy — Completed
• Efficacy and Safety Study of Reslizumab to Treat Poorly Controlled Asthma — Completed
• A Study to Evaluate the Safety and Tolerability of a Nasal Spray to Treat Perennial Allergic Rhinitis — Completed
• Efficacy Study of Sublingual Immunotherapy to Treat Ragweed Allergies — Completed
• A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma — Completed
• A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies — Completed
• Evaluate the Effect of Omalizumab on Markers of Asthma Impairment in Patients With Persistent Allergic Asthma — Completed
• A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Perennial Allergies — Completed
• A Study of the Treatment-Sparing Effects of AEROVANT™ AER 001 Inhalation Powder in Asthma Patients, AEROTRIAL — Completed
• A Study to Evaluate the Safety and Efficacy of Two Nasal Sprays to Treat Seasonal Allergies — Completed